Interstitial Lung Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults between 18 and 75 years old, both male and female, are eligible to be considered.
• People who have given their written agreement (informed consent) to take part.
• People who have a confirmed diagnosis of one of the following conditions: Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA), Sjögren's Syndrome (SS), Inflammatory Muscle Disease (IIM), or Undifferentiated Connective Tissue Disease (UCTD), diagnosed according to internationally recognised medical standards.
• People whose blood test results show specific markers that indicate a higher risk of developing lung scarring (ILD), with the specific markers required depending on which condition has been diagnosed (confirm with trial site for details).
• People who have evidence of lung changes on a specialised lung scan (HRCT) showing that at least 10% of the lung tissue is affected, with the scan performed within the previous 6 weeks — or, for some participants, a recent scan showing no such changes may also be considered.
• People who are either not currently taking immune-suppressing medications, or who have been on a stable dose of such medications for at least three months before the relevant blood test is done.

Who may not be able to join:

• People currently taking corticosteroid medication (such as prednisone) at a dose higher than 10 mg per day.
• People who have received the medication rituximab within the past 24 weeks.
• People whose veins are difficult to access in a way that would make blood collection problematic.

Important: Always verify eligibility with the trial site directly before applying.